3Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock :2008[J].Crit Care Med,2008,36 ( 1 ) :296 - 327.
4Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes [ J ]. Diabetes Care,2003,26 ( 2 ) : 510 - 513.
5Cariou A,Vinsonneau C, Dhainaut JF. Adjunctive therapies in sepsis: an evidence -based review[J]. Crit Care Med,2004,32( 11 Suppl) : 562 - 570.
6van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients [ J ]. N Engl J Med, 2001,345 (19) :1359 -1367.
7van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU [ J ]. N Engl J Med, 2006,354 ( 5 ) : 449 -461.
8Wong WM, Wong BC, Hui CK, et al. Pyogenic liver abscess:retrospective analysis of 80 cases over a 10-year period. J Gastroenterol Hepatol, 2002,17 : 1001-1007.
9Haddy RI, Nadkarni DD, Mann BL, et al. Clostridial bacteremia in the community hospital. Scand J Infect Dis,2000,32 : 27-30.
